YERVOY (ipilimumab) Patient Assistance Program
Don’t let the high cost of brand specialty cancer immunotherapy stand between you and the treatment you need. We help eligible patients access Yervoy (ipilimumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Yervoy (ipilimumab) is FDA-approved for unresectable or metastatic melanoma in adults and pediatric patients 12 and older (alone or with nivolumab), for adjuvant treatment of completely resected cutaneous melanoma with regional lymph-node involvement, and as first-line treatment of intermediate- or poor-risk advanced renal cell carcinoma in combination with nivolumab.
- Without assistance, list pricing for Yervoy is approximately $7,300 per 50 mg vial and $29,000–$35,000 per 200 mg vial. Per-infusion totals are weight-based and commonly range $30,000–$40,000 at the 3 mg/kg melanoma dose. A full melanoma course of four doses can total $120,000 or more.
- Through AffordMyPrescriptions, qualifying patients can access Yervoy coverage for a flat $69.95 per month — our advocacy team manages the entire enrollment, infusions, and renewal process.
- There is no FDA-approved biosimilar to Yervoy available in the U.S. as of 2026.
What is Yervoy Prescription Assistance Program?
The Yervoy Prescription Assistance Program is a manufacturer-sponsored initiative that provides Yervoy infusions at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for cancer patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, infusion scheduling, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through infusion-schedule coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Yervoy infusions cost roughly $30,000–$40,000 each at the 3 mg/kg melanoma dose. Pharmacy discount coupons are not a meaningful tool for IV therapy. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| 50 mg vial (list) | ~$7,300.00 | Save ~$7,230/vial |
| 200 mg vial (list) | ~$32,000.00 | Save ~$31,930/vial |
| Per infusion (3 mg/kg) | ~$35,000.00 | Save ~$34,930/dose |
| 4-dose melanoma course | ~$140,000+ | Save ~$139,000+ total |
| Combo with Opdivo | ~$45,000+/cycle | Save thousands/cycle |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Yervoy Prescription Program?
The Patient Assistance Program is free to apply for and provides Yervoy infusions at little or no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-authorization documentation, infusion scheduling, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, infusion scheduling, documentation, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Yervoy:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $30,000–$40,000 per infusion per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Yervoy assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Yervoy Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Yervoy:
Yervoy (ipilimumab) is an intravenous (IV) immunotherapy used to treat advanced melanoma and advanced renal cell carcinoma (kidney cancer). It belongs to a class of medicines called CTLA-4 checkpoint inhibitors and is given by infusion in a clinic, infusion center, or hospital outpatient setting on a defined schedule, often in combination with the PD-1 inhibitor nivolumab.
How It Works:
Yervoy is a “checkpoint inhibitor” that works by blocking CTLA-4, a protein that acts as a natural brake on the immune system. By physically obstructing this protein, the medication allows T cells to fully activate and multiply, strengthening the body’s natural attack against cancer cells. While this released immune response can lead to long-lasting results, it also increases the risk of the immune system attacking healthy organs.
Form and Use:
This medication is administered as an IV infusion, with the specific dosage and schedule depending on the type of cancer being treated. For melanoma, it is typically given at 3 mg/kg every three weeks for a set number of doses, while for kidney cancer, it is used at a lower dose in combination with other immunotherapies. Your oncology team will follow a regimen tailored to your specific diagnosis and stage of treatment.
Generic Availability:
As of 2026, there is no FDA-approved biosimilar version of Yervoy available in the United States. Because it is a complex biologic medicine, any future alternative would need to pass a specialized regulatory pathway rather than a traditional generic route. While other immunotherapy regimens exist for similar cancers, the decision to use Yervoy versus another checkpoint inhibitor depends on your specific biomarkers and prior treatment history.
Warnings:
Yervoy carries significant warnings for immune-related side effects that can impact various organs, including the lungs, liver, intestines, and skin. It is vital to promptly report symptoms such as persistent diarrhea, shortness of breath, or yellowing of the skin to your oncology team, as early detection is key to management. Patients should also be monitored for severe reactions during the infusion itself.
FAQ (Frequently Asked Questions)
How Much Does Yervoy Cost Without Insurance?
List pricing is approximately $7,300 per 50 mg vial and $29,000–$35,000 per 200 mg vial. Per-infusion totals are weight-based and commonly range $30,000–$40,000 at the 3 mg/kg melanoma dose; a full four-dose course can total $120,000+. Through AffordMyPrescriptions, qualifying patients receive Yervoy infusions at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Yervoy Different From Opdivo (Nivolumab)?
Yervoy and Opdivo are different checkpoint inhibitors that work on different immune brakes. Yervoy blocks CTLA-4, and Opdivo blocks PD-1. They are often used together because the combination releases two different brakes at once. Combination therapy can produce stronger responses but also more frequent immune-related side effects than either drug alone.
What Kinds Of Side Effects Should I Watch For?
Because Yervoy activates the immune system through CTLA-4 blockade, the most characteristic side effects are immune-related — meaning they occur when the immune system attacks normal tissue. These can affect the lungs, intestines, liver, kidneys, skin, endocrine glands, nervous system, and other organs. Tell your oncology team promptly about persistent diarrhea, new cough or shortness of breath, yellowing of the skin or eyes, severe rash, or any new symptom.
Can I Get Yervoy Through The PAP If I Have Medicare?
Yes. Medicare beneficiaries can typically qualify for Yervoy Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. The manufacturer’s commercial copay assistance program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.Yes. Medicare Part D beneficiaries can typically qualify for Betaseron Patient Assistance, especially if you have not yet reached catastrophic coverage or are facing specialty-tier copays you cannot afford. Note that the manufacturer’s commercial copay card is a separate program reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent foundations such as the PAN Foundation or HealthWell Foundation, disease-specific organizations like the Melanoma Research Foundation or Kidney Cancer Association, the manufacturer’s copay assistance program if you have commercial insurance, or asking your oncology team whether a different immunotherapy regimen would be appropriate. If we cannot find a path, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients see their first covered Yervoy infusion within two to four weeks of completing the documentation. Timing depends on how quickly your oncology team returns the required forms and the program processes your application.
Take Control of Your Medication Costs
If you are struggling with the high cost of Yervoy, our team may be able to help you access assistance programs designed to make brand specialty cancer immunotherapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.